Skip Navigation
Search Menu

Wilmer Eye Institute
 
Print This Page
Share this page: More
 

Dr. Hendrik Scholl Shares Thoughts on Gene Therapy for Retinal Diseases

1/17/2014

Dr. Hendrik Scholl, a professor of ophthalmology in Wilmer's retina division, contributed an editorial on a recent study on the effectiveness of gene therapy to treat progressive retinal diseases. The results of the study, whick took place at Oxford Eye Hospital in the U.K., were published by Lancet on January 16 and indicated that a group of patients with choroideremia, an inherited retinal disease which leads to blindness by middle age, showed some improvement in vision after receiving a single injection of gene therapy. Dr. Scholl was chosen by Lancet to comment on the study given his expertise in inherited retinal and macular degenerations.

The full study is also available on Science Direct, with Dr. Scholl's comment also available.

Dr. Scholl was interviewed on Canada's CTV network's morning news program about the positive implications of the study.

Sanford Greenberg Elected to the American Academy of Arts and Sciences

Dr. Jennifer Thorne Appointed President-elect of American Uveitis Society- 5/17/16

Dr. Ingrid Zimmer-Galler Elected to the ATA College of Fellows- 5/13/16

Dr. Arevalo Launches New Book at ARVO 2016- 5/09/16

Dr. Elia J. Duh is elected to the American Society for Clinical Investigation- 4/28/16

Dr. Maria Valeria Canto Soler Wins BrightFocus Award for Macular Degeneration Research- 4/27/16

Three Wilmer Faculty Voted Most Influential in Field of Ophthalmology- 4/22/2016

Dr. Pradeep Ramulu Wins Pisart Award for Significant Achievement in Vision Science Research- 4/21/16

Dr. Eghrari Receives Alcon Early Career Research Award- 4/13/16

Dr. Quigley Honored by American Glaucoma Society- 4/11/16

Dr. Ian Pitha Awarded Grants for Glaucoma Research- 4/11/16

READ MORE NEWS HERE